William Heiden

Amag CEO to step down as troubled pharma looks to sell 2 drugs
BioPharma Dive
Thu, 01/9/20 - 04:03 pm
Amag Pharmaceuticals
restructuring
Vyleesi
Intrarosa
William Heiden